2018
DOI: 10.2298/jsc171112065la
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of the dissolution profile of the diuretic hydrochlorothiazide by elaboration of microspheres

Abstract: Hydrochlorothiazide (HCTZ), which was developed and introduced in the late 1950s, is still one of the most frequently employed drugs in antihypertensive treatments. Its poor aqueous solubility is one of the reasons for its limited bioavailability after oral administration. The present paper provides details of the preparation of HCTZ-loaded microspheres by the solvent evaporation technique. A total of seven formulations were prepared using ethyl cellulose, poly(?-caprolactone) (PCL), ?-cyclodextrin (?-CD) and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…The release profile of the drug from different crystal products was estimated in a USP XXIII dissolution testing apparatus (Dissolution tester (USP) TDT06L, Electrolab) using rotating paddle method. 10,18 For the experiment, a weighed amount of powder sample of LT (100 mg) and selected crystal products (100 mg equivalent LT) were placed in a dissolution vessel rotated at 50 rpm at 37±0.5 °C. Simulated gastric fluid (900 ml of 0.1 M HCl at pH 1.2) was taken as the release medium.…”
Section: In Vitro Characterizationmentioning
confidence: 99%
“…The release profile of the drug from different crystal products was estimated in a USP XXIII dissolution testing apparatus (Dissolution tester (USP) TDT06L, Electrolab) using rotating paddle method. 10,18 For the experiment, a weighed amount of powder sample of LT (100 mg) and selected crystal products (100 mg equivalent LT) were placed in a dissolution vessel rotated at 50 rpm at 37±0.5 °C. Simulated gastric fluid (900 ml of 0.1 M HCl at pH 1.2) was taken as the release medium.…”
Section: In Vitro Characterizationmentioning
confidence: 99%
“…However, being a class II type drug (under Biopharmaceutical Classification System), the main problem associated with the oral administration is its extremely low solubility in aqueous media. 7,8 Thus, its dissolution rate is the major limiting step for the successful absorption of the drug to achieve desired onset of action. Several advanced formulation techniques have been reported over the past years to improve the solubility and bioavailability of IBU.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, several carrier systems have recently been used to produce fast-release solid formulations. Cellulose derivatives such as ethylcellulose (EC) [11][12][13][14][15][16][17][18] and hydroxypropylmethylcellulose HPMC [12,15,19,20] with non-toxic and non-irritating properties, as well as hydrophilic properties, were selected for the development of controlled-release technology in the formulation of pharmaceutical products.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the biocompatibilities of different biodegradable polymers such as poly (ε-caprolactone) PCL [18,21,22,23] as candidate materials for different biomedical applications have been extensively investigated. Then, due to their broad spectrum of physical properties and hydrolytic degradation profiles, they have become attractive candidates for human use as surgical sutures, implantable devices, and drug delivery systems by the United States Food and Drug Administration (FDA) [24][25][26].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation